Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.
about
Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.Central nervous system cancersManagement of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
P2860
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Carboplatin and teniposide as ...... astrocytoma: a phase II study.
@ast
Carboplatin and teniposide as ...... astrocytoma: a phase II study.
@en
type
label
Carboplatin and teniposide as ...... astrocytoma: a phase II study.
@ast
Carboplatin and teniposide as ...... astrocytoma: a phase II study.
@en
prefLabel
Carboplatin and teniposide as ...... astrocytoma: a phase II study.
@ast
Carboplatin and teniposide as ...... astrocytoma: a phase II study.
@en
P2093
P50
P356
P1433
P1476
Carboplatin and teniposide as ...... oastrocytoma: a phase II study
@en
P2093
L M Pasetto
P304
P356
10.1093/ANNONC/MDG494
P577
2003-12-01T00:00:00Z